arrow
R

Rosa Iodice

university of naples federico ii
H指数:30
被引数:3,408

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct sensory and autonomic involvement in hypermobile Ehlers–Danlos syndrome compared with idiopathic small fiber neuropathy: a multimodal study

与特发性小纤维神经病相比,高弹性埃勒斯-当洛斯综合征中感觉和自主神经的差异性参与:一项多模式研究

2026-07-030
OA
Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Clinical Features, Diagnostic Challenges, and the Role of Oxidative Stress in Pathophysiology

迟发型多酰基辅酶A脱氢酶缺乏症(MADD):临床特征、诊断挑战以及氧化应激在病理生理学中的作用

2025-11-260
OAAI
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study

多发性硬化患者S1P受体调节剂所致淋巴细胞减少症谱的实世界比较:一项多中心回顾性研究

2025-08-060
OAAI
In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations

在体评估治疗抵抗性精神分裂症中GABA能抑制和谷氨酸能易化的方法:一项整合临床、认知及神经生理学评估的TMS研究

2025-06-190
OAAI
Intra- and Extra-Hospitalization Monitoring of Vital Signs-Two Sides of the Same Coin: Perspectives from LIMS and Greenline-HT Study Operators
SENSORS
IF3.5
2023-06-075
OAAI
Efficacy of recanalization therapy for ischemic stroke: multicenter hospital network experience
2023-02-080
OAAI
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies
2022-06-2335
OA
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

克拉屈滨在多发性硬化症中有效性和安全性的预测因素: 一项真实世界,多中心,2年随访研究

2022-06-0229
OAAI